These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Various aspects of treatment of primary melanoblastoma of the extremities by regional perfusion]. Schraffordt Koops H; Eibergen R; Oldhoff J; van der Ploegen E; Vermey A Ned Tijdschr Geneeskd; 1975 Nov; 119(45):1746-53. PubMed ID: 1214883 [No Abstract] [Full Text] [Related]
6. [Surgical treatment and regional chemotherapy in melanoma of the extremities]. Henneking K; Binder J; Weyers W; Schwemmle K Chirurg; 1993 Feb; 64(2):134-8. PubMed ID: 8462350 [TBL] [Abstract][Full Text] [Related]
7. Four times repeated isolated limb infusion with melphalan-controlled locoregional disease in the patient with melanoma of the leg. El Halabi H; Hijaz F; Gushchin V Am Surg; 2012 Dec; 78(12):E504-5. PubMed ID: 23265100 [No Abstract] [Full Text] [Related]
8. Efficacy of repeat isolated limb perfusions with tumor necrosis factor alpha and melphalan for multiple in-transit metastases in patients with prior isolated limb perfusion failure. Grünhagen DJ; van Etten B; Brunstein F; Graveland WJ; van Geel AN; de Wilt JH; Eggermont AM Ann Surg Oncol; 2005 Aug; 12(8):609-15. PubMed ID: 15968498 [TBL] [Abstract][Full Text] [Related]
9. [Hyperthermic isolation perfusion of the extremities in malignant melanomas and soft tissue sarcomas]. Tonak J; Hohenberger W; Göhl J Chirurg; 1984 Aug; 55(8):499-504. PubMed ID: 6488994 [No Abstract] [Full Text] [Related]
10. [Regional hyperthermic perfusion in malignant melanoma of the extremities--controlled studies (proceedings)]. Hafström L; Jönsson PE Lakartidningen; 1978 Dec; 75(49):4599-600. PubMed ID: 723351 [No Abstract] [Full Text] [Related]
11. [Extensive lymphadenectomy and perfusion chemotherapy in the treatment of pigmented skin tumors of the lower extremities]. Kolesov VI; Levin AO; Martyniuk VV; Sidorenko LN; Stepanova NS Vestn Khir Im I I Grek; 1970 Jun; 104(6):68-73. PubMed ID: 4992349 [No Abstract] [Full Text] [Related]
12. [Value of perfusion and infusion in the treatment of malignant melanoma of the lower extremities]. Meyza J Pediatr Pol; 1986 Aug; 61(8):521-3. PubMed ID: 3575001 [No Abstract] [Full Text] [Related]
13. Isolated limb perfusion: what is the evidence for its use? Noorda EM; Vrouenraets BC; Nieweg OE; Van Coevorden F; Kroon BB Ann Surg Oncol; 2004 Sep; 11(9):837-45. PubMed ID: 15313738 [TBL] [Abstract][Full Text] [Related]
15. Isolated limb perfusion with melphalan for the treatment of intractable primary cutaneous diffuse large B-cell lymphoma leg type. Kobold S; Killic N; Lütkens T; Bokemeyer C; Fiedler W Acta Haematol; 2010; 123(3):179-81. PubMed ID: 20224270 [No Abstract] [Full Text] [Related]
16. Factors predictive of acute regional toxicity after isolated limb infusion with melphalan and actinomycin D in melanoma patients. Kroon HM; Moncrieff M; Kam PC; Thompson JF Ann Surg Oncol; 2009 May; 16(5):1184-92. PubMed ID: 19224289 [TBL] [Abstract][Full Text] [Related]
17. Repeat isolated limb perfusion with melphalan for recurrent melanoma of the limbs. Klop WM; Vrouenraets BC; van Geel BN; Eggermont AM; Klaase JM; Nieweg OE; Kroon BB J Am Coll Surg; 1996 Jun; 182(6):467-72. PubMed ID: 8646345 [TBL] [Abstract][Full Text] [Related]
18. Review of regional limb perfusion with melphalan for malignant melanoma. Irvine WT; Luck RJ Br Med J; 1966 Mar; 1(5490):770-4. PubMed ID: 5910107 [No Abstract] [Full Text] [Related]